FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC

R. Boellaard | A. Einstein | J. Bucerius | S. Dorbala | T. Bley | F. Hyafil | A. Abidov | M. Walter | E. Miller | Wengen Chen | A. Versari | A. Saraste | R. Sciagrà | R. Delgado-Bolton | F. Lomeña | R. Slart | D. Blockmans | P. Chareonthaitawee | E. Brouwer | A. Signore | A. Glaudemans | R. Beanlands | H. Verberne | A. Gimelli | O. Gheysens | D. Agostini | R. Luqmani | G. Treglia | F. Besson | C. Salvarani | A. Voskuyl | M. Cimmino | Shaifali Jain | M. Massollo | M. Cid | A. Roivainen | S. Prieto-González | C. J. van der Laken | D. Camellino | M. Schirmer | T. Klink | J. Carril | Riemer H. J. A. Andor W. J. M. Panithaya Giorgio Florent Slart Glaudemans Chareonthaitawee Treglia B | Bhaskar Dagupta | Aiden Denis Rob S. Roberto C. Andrew J. Alessia Edward J Abidov Agostini Beanlands Delgado-Bolton Ei | Riemer H. J. A. Jan Fabien Hein J. Denis Alessia Roberto Slart Bucerius Hyafil Verberne Agostini Gim | Andor W. J. M. Giorgio Olivier Annibale Alberto Glaudemans Treglia Gheysens Versari Signore | Panithaya Wengen Sharmila Chareonthaitawee Chen Dorbala | Andor W. J. M. Giorgio Florent L. Thorsten A. Daniel Ron Glaudemans Treglia Besson Bley Blockmans Bo | Panithaya Sharmila Aiden Rob S. Andrew J. Edward J. Chareonthaitawee Dorbala Abidov Beanlands Einste | R. Slart | Anne Roivainen | Riemer H. J. A. Andor W. J. M. Panithaya Giorgio Florent Slart Glaudemans Chareonthaitawee Treglia | Aiden Denis Rob S. Roberto C. Andrew J. Alessia Edward J Abidov Agostini Beanlands Delgado-Bolton Ei | Riemer H. J. A. Jan Fabien Hein J. Denis Alessia Roberto Slart Bucerius Hyafil Verberne Agostini Gim | Andor W. J. M. Giorgio Florent L. Thorsten A. Daniel Ron Glaudemans Treglia Besson Bley Blockmans Bo | Panithaya Sharmila Aiden Rob S. Andrew J. Edward J. Chareonthaitawee Dorbala Abidov Beanlands Einste

[1]  A. Iagnocco,et al.  EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice , 2018, Annals of the rheumatic diseases.

[2]  R. Boellaard,et al.  Variability in quantitative analysis of atherosclerotic plaque inflammation using 18F-FDG PET/CT , 2017, PloS one.

[3]  L. Cooper,et al.  Joint SNMMI–ASNC Expert Consensus Document on the Role of 18F-FDG PET/CT in Cardiac Sarcoid Detection and Therapy Monitoring , 2017, The Journal of Nuclear Medicine.

[4]  A. Aouba,et al.  Giant-cell arteritis: concordance study between aortic CT angiography and FDG-PET/CT in detection of large-vessel involvement , 2017, European Journal of Nuclear Medicine and Molecular Imaging.

[5]  L. Gormsen,et al.  OP0285 Attenuation of fluorine-18-fluorodeoxyglucose uptake in large vessel giant cell arteritis after short-term high-dose steroid treatment – a diagnostic window of opportunity , 2017 .

[6]  B. Krämer,et al.  The value of ultrasound in diagnosing extracranial large-vessel vasculitis compared to FDG-PET/CT: A retrospective study , 2017, Clinical Rheumatology.

[7]  J. Krischer,et al.  A Randomized, Double‐Blind Trial of Abatacept (CTLA‐4Ig) for the Treatment of Giant Cell Arteritis , 2017, Arthritis & rheumatology.

[8]  J. Krischer,et al.  A Randomized, Double‐Blind Trial of Abatacept (CTLA‐4Ig) for the Treatment of Takayasu Arteritis , 2017, Arthritis & rheumatology.

[9]  P. Merkel,et al.  Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy , 2017, Scientific Reports.

[10]  G. Hunder,et al.  Clinical and Pathological Evolution of Giant Cell Arteritis: A Prospective Study of Follow-Up Temporal Artery Biopsies in 40 Treated Patients , 2017, Modern Pathology.

[11]  R. Benti,et al.  18F-FDG uptake in main arterial branches of patients with large vessel vasculitis: visual and semiquantitative analysis , 2016, Annals of Nuclear Medicine.

[12]  M. Eiber,et al.  Fully integrated whole-body [18F]-fludeoxyglucose positron emission tomography/magnetic resonance imaging in therapy monitoring of giant cell arteritis. , 2016, European heart journal.

[13]  D. Misra,et al.  Cardiac involvement in primary systemic vasculitis and potential drug therapies to reduce cardiovascular risk , 2016, Rheumatology International.

[14]  Y. H. Lee,et al.  Diagnostic accuracy of 18F-FDG PET or PET/CT for large vessel vasculitis , 2016, Zeitschrift für Rheumatologie.

[15]  J. Bucerius,et al.  Position paper of the Cardiovascular Committee of the European Association of Nuclear Medicine (EANM) on PET imaging of atherosclerosis , 2015, European Journal of Nuclear Medicine and Molecular Imaging.

[16]  R. Quirce,et al.  (18)F-FDG PET/CT for the detection of large vessel vasculitis in patients with polymyalgia rheumatica. , 2015, Revista espanola de medicina nuclear e imagen molecular.

[17]  R. Slart,et al.  OP0236 Different Scoring Methods of FDG PET/CT in Giant Cell Arteritis: Need for Standardization , 2015 .

[18]  M. Soussan,et al.  THU0272 Diagnostic Performance and Disease Activity Assessment by FDG-PET in Large-Vessel Vasculitis: A Systematic Literature Review and Meta-Analysis , 2015 .

[19]  Z. Bortlíček,et al.  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015 Dec; 159(4) , 2015 .

[20]  S. Houshmand,et al.  Quantifying [18F]fluorodeoxyglucose uptake in the arterial wall: the effects of dual time-point imaging and partial volume effect correction , 2015, European Journal of Nuclear Medicine and Molecular Imaging.

[21]  M. Soussan,et al.  Management of Large-Vessel Vasculitis With FDG-PET , 2015, Medicine.

[22]  Pauline Huet,et al.  Variability and Uncertainty of 18F-FDG PET Imaging Protocols for Assessing Inflammation in Atherosclerosis: Suggestions for Improvement , 2015, The Journal of Nuclear Medicine.

[23]  S. Houshmand,et al.  Assessment of atherosclerosis in large vessel walls: A comprehensive review of FDG-PET/CT image acquisition protocols and methods for uptake quantification , 2015, Journal of Nuclear Cardiology.

[24]  H. Direskeneli,et al.  Patients with Takayasu's arteritis having persistent acute-phase response usually have an increased major vessel uptake by 18F-FDG-PET/CT , 2015, Modern rheumatology.

[25]  Marcelo Sánchez,et al.  Effect of Glucocorticoid Treatment on Computed Tomography Angiography Detected Large-Vessel Inflammation in Giant-Cell Arteritis. A Prospective, Longitudinal Study , 2015, Medicine.

[26]  E. Comans,et al.  Large-Vessel Vasculitis: Interobserver Agreement and Diagnostic Accuracy of 18F-FDG-PET/CT , 2015, BioMed research international.

[27]  M. Essler,et al.  Imaging large vessel vasculitis with fully integrated PET/MRI: a pilot study , 2015, European Journal of Nuclear Medicine and Molecular Imaging.

[28]  Eric J. W. Visser,et al.  FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0 , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[29]  Thorsten Klink,et al.  Reducing CT radiation dose with iterative reconstruction algorithms: the influence of scan and reconstruction parameters on image quality and CTDIvol. , 2014, European journal of radiology.

[30]  R. Quirce,et al.  Assessment of aortitis by semiquantitative analysis of 180-min 18F-FDG PET/CT acquisition images , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[31]  Sanjay Jain,et al.  F-18 FDG PET/CT in the evaluation of Takayasu arteritis: An experience from the tropics , 2014, Journal of Nuclear Cardiology.

[32]  T. Witte,et al.  Large vessel vasculitis and spondyloarthritis: coincidence or associated diseases? , 2014, Scandinavian journal of rheumatology.

[33]  J. Grau,et al.  Positron emission tomography assessment of large vessel inflammation in patients with newly diagnosed, biopsy-proven giant cell arteritis: a prospective, case–control study , 2014, Annals of the rheumatic diseases.

[34]  T. Kano,et al.  Large vessel vasculitis in elderly patients: early diagnosis and steroid-response evaluation with FDG-PET/CT and contrast-enhanced CT , 2014, Rheumatology International.

[35]  Mahboob Rahman,et al.  Changes in biomarkers after therapeutic intervention in temporal arteries cultured in Matrigel: a new model for preclinical studies in giant-cell arteritis , 2013, Annals of the rheumatic diseases.

[36]  V. Aboyans,et al.  [2014 ESC Guidelines on the diagnosis and treatment of aortic diseases]. , 2014, Kardiologia polska.

[37]  V. Fuster,et al.  Optimizing 18F-FDG PET/CT imaging of vessel wall inflammation: the impact of 18F-FDG circulation time, injected dose, uptake parameters, and fasting blood glucose levels , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[38]  Z. Řehák,et al.  Comment on: FDG PET in the early diagnosis of large-vessel vasculitis , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[39]  Bing Bai,et al.  Tumor Quantification in Clinical Positron Emission Tomography , 2013, Theranostics.

[40]  F. Paparo,et al.  High frequency of capsular knee involvement in polymyalgia rheumatica/giant cell arteritis patients studied by positron emission tomography. , 2013, Rheumatology.

[41]  V. Dilsizian,et al.  SNMMI/ASNC/SCCT Guideline for Cardiac SPECT/CT and PET/CT 1.0* , 2013, The Journal of Nuclear Medicine.

[42]  P. Christian,et al.  EANM/SNMMI Guideline for 18F-FDG Use in Inflammation and Infection* , 2013, The Journal of Nuclear Medicine.

[43]  K. Aksu,et al.  Comparison of F18-FDG PET/CT findings with current clinical disease status in patients with Takayasu's arteritis. , 2013, Clinical and experimental rheumatology.

[44]  Z Wang,et al.  18-FDG-PET in assessing disease activity in Takayasu arteritis: a meta-analysis. , 2013, Clinical and experimental rheumatology.

[45]  P. Merkel,et al.  2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. , 2013, Arthritis and rheumatism.

[46]  D. Agostini,et al.  Towards an optimal semiquantitative approach in giant cell arteritis: an 18F-FDG PET/CT case-control study , 2013, European Journal of Nuclear Medicine and Molecular Imaging.

[47]  M. Centonze,et al.  Diagnosis of large-vessel vasculitis using [18F]-FDG PET-CT , 2013, La radiologia medica.

[48]  T. Kano,et al.  Whole-body fluorodeoxyglucose positron emission tomography/computed tomography in patients with active polymyalgia rheumatica: evidence for distinctive bursitis and large-vessel vasculitis , 2012, Modern rheumatology.

[49]  K. Hirao,et al.  Role of FDG PET-CT in Takayasu arteritis: sensitive detection of recurrences. , 2012, JACC. Cardiovascular imaging.

[50]  Yong-Beom Park,et al.  F-Fluorodeoxyglucose–Positron Emission Tomography in the Assessment of Disease Activity in Patients With Takayasu Arteritis , 2011 .

[51]  R. Slart,et al.  Parameters related to a positive test result for FDG PET(/CT) for large vessel vasculitis: a multicenter retrospective study , 2012, Clinical Rheumatology.

[52]  Marcelo Sánchez,et al.  Large vessel involvement in biopsy-proven giant cell arteritis: prospective study in 40 newly diagnosed patients using CT angiography , 2012, Annals of the rheumatic diseases.

[53]  M. Briel,et al.  The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitis , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[54]  Mahboob Rahman,et al.  Tissue and serum markers of inflammation during the follow-up of patients with giant-cell arteritis—a prospective longitudinal study , 2011, Rheumatology.

[55]  G. Raff,et al.  SCCT guidelines on radiation dose and dose-optimization strategies in cardiovascular CT. , 2011, Journal of cardiovascular computed tomography.

[56]  John O. Prior,et al.  Diagnostic performance of 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a systematic review and meta-analysis , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[57]  P. Bartenstein,et al.  Patterns of extracranial involvement in newly diagnosed giant cell arteritis assessed by physical examination, colour coded duplex sonography and FDG-PET. , 2011, VASA. Zeitschrift fur Gefasskrankheiten.

[58]  Natsuko Miura,et al.  Role of imaging studies in the diagnosis and evaluation of giant cell arteritis in Japanese: report of eight cases , 2011, Modern rheumatology.

[59]  L. Kanz,et al.  Cyclophosphamide for large vessel vasculitis: assessment of response by PET/CT. , 2011, Clinical and experimental rheumatology.

[60]  B. Dasgupta.  Concise guidance: diagnosis and management of giant cell arteritis. , 2010, Clinical medicine.

[61]  Z. Keidar,et al.  Do Hyperglycemia and Diabetes Affect the Incidence of False-Negative 18F-FDG PET/CT Studies in Patients Evaluated for Infection or Inflammation and Cancer? A Comparative Analysis , 2010, Journal of Nuclear Medicine.

[62]  A. Rademacher,et al.  Fever of unknown origin as initial manifestation of large vessel giant cell arteritis: diagnosis by colour-coded sonography and 18-FDG-PET. , 2010, Clinical and experimental rheumatology.

[63]  S. Morbelli,et al.  Methotrexate treatment of polymyalgia rheumatica/giant cell arteritis-associated large vessel vasculitis. , 2010, Clinical and experimental rheumatology.

[64]  J. Marienhagen,et al.  18F-FDG PET as a diagnostic procedure in large vessel vasculitis—a controlled, blinded re-examination of routine PET scans , 2010, Clinical Rheumatology.

[65]  F. Bertagna,et al.  Role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography for therapy evaluation of patients with large-vessel vasculitis , 2010, Japanese Journal of Radiology.

[66]  W. D. van Marken Lichtenbelt,et al.  Cold-activated brown adipose tissue in healthy men. , 2009, The New England journal of medicine.

[67]  Chang-Keun Lee,et al.  Evaluation of Disease Activity Using F-18 FDG PET-CT in Patients With Takayasu Arteritis , 2009, Clinical nuclear medicine.

[68]  K. Maksimowicz-McKinnon,et al.  Takayasu Arteritis and Giant Cell Arteritis: A Spectrum Within the Same Disease? , 2009, Medicine.

[69]  P. Cluzel,et al.  Is (18)F-fluorodeoxyglucose positron emission tomography scanning a reliable way to assess disease activity in Takayasu arteritis? , 2009, Arthritis and rheumatism.

[70]  S. Ben-Haim,et al.  Cardiovascular infection and inflammation. , 2009, Seminars in nuclear medicine.

[71]  T. Bley,et al.  Imaging for large-vessel vasculitis , 2009, Current opinion in rheumatology.

[72]  A. Heinzel,et al.  Assessment of Large-Vessel Involvement in Giant Cell Arteritis with 18F-FDG PET: Introducing an ROC-Analysis–Based Cutoff Ratio , 2008, Journal of Nuclear Medicine.

[73]  Sameer Bansilal,et al.  Atherosclerosis Inflammation Imaging with 18F-FDG PET: Carotid, Iliac, and Femoral Uptake Reproducibility, Quantification Methods, and Recommendations , 2008, Journal of Nuclear Medicine.

[74]  M. Cimmino,et al.  Is FDG-PET useful in the evaluation of steroid-resistant PMR patients? , 2008, Rheumatology.

[75]  E. Batard,et al.  Aortic involvement in recent-onset giant cell (temporal) arteritis: a case-control prospective study using helical aortic computed tomodensitometric scan. , 2008, Arthritis and rheumatism.

[76]  U. Hoffmann,et al.  Giant cell arteritis: a systemic vascular disease , 2008, Vascular medicine.

[77]  L. Kanz,et al.  [18F] FDG-PET/CT as a new and sensitive imaging method for the diagnosis of large vessel vasculitis. , 2008, Clinical and experimental rheumatology.

[78]  M. Heller,et al.  MRI and FDG-PET in the assessment of inflammatory aortic arch syndrome in complicated courses of giant cell arteritis , 2008, Annals of the rheumatic diseases.

[79]  A. Versari,et al.  Role of imaging studies in the diagnosis and follow-up of large-vessel vasculitis: an update. , 2007, Rheumatology.

[80]  V. Gerbaudo,et al.  Low-Dose Oral Propranolol Could Reduce Brown Adipose Tissue F-18 FDG Uptake in Patients Undergoing PET Scans , 2007, Clinical nuclear medicine.

[81]  L. Mortelmans,et al.  Repetitive 18-fluorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatica: a prospective study in 35 patients. , 2005, Rheumatology.

[82]  Ahmed Tawakol,et al.  In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. , 2006, Journal of the American College of Cardiology.

[83]  L. Mortelmans,et al.  Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients. , 2006, Arthritis and rheumatism.

[84]  A. Freiman,et al.  Association of vascular 18F-FDG uptake with vascular calcification. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[85]  K. Ishii,et al.  Aortic wall inflammation due to Takayasu arteritis imaged with 18F-FDG PET coregistered with enhanced CT. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[86]  Sidor Misović,et al.  [Takayasu arteritis]. , 2005, Medicinski pregled.

[87]  Christian Schindler,et al.  The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[88]  Ora Israel,et al.  Evaluation of 18F-FDG uptake and arterial wall calcifications using 18F-FDG PET/CT. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[89]  F. Strutz,et al.  Diagnosis and follow up of aortitis in the elderly , 2004, Annals of the rheumatic diseases.

[90]  D. Pennell,et al.  Non-invasive imaging in the diagnosis and management of Takayasu’s arteritis , 2004, Annals of the rheumatic diseases.

[91]  E. Henze,et al.  Correlation between 18-fluorodeoxyglucose accumulation in large vessels and serological markers of inflammation in polymyalgia rheumatica: a quantitative PET study , 2004, Annals of the rheumatic diseases.

[92]  M. Bijl,et al.  Additional value of positron emission tomography in diagnosis and follow-up of patients with large vessel vasculitides. , 2004, Clinical and experimental rheumatology.

[93]  A. Al-nahhas,et al.  The role of 18F-FDG PET in characterising disease activity in Takayasu arteritis , 2004, European Journal of Nuclear Medicine and Molecular Imaging.

[94]  W. Oyen,et al.  F-18-fluorodeoxyglucose positron emission tomography in diagnosis and follow-up of patients with different types of vasculitis. , 2003, The Netherlands journal of medicine.

[95]  F. Strutz,et al.  Early diagnosis and follow-up of aortitis with [18F]FDG PET and MRI , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[96]  H. Zhuang,et al.  Do high glucose levels have differential effect on FDG uptake in inflammatory and malignant disorders? , 2001, Nuclear medicine communications.

[97]  M. Gravanis.  Giant cell arteritis and Takayasu aortitis: morphologic, pathogenetic and etiologic factors. , 2000, International journal of cardiology.

[98]  A. Maes,et al.  Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch. , 2000, The American journal of medicine.

[99]  J. Nuyts,et al.  New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography. , 1999, Rheumatology.

[100]  I. Yamada,et al.  Takayasu arteritis: evaluation of the thoracic aorta with CT angiography. , 1998, Radiology.

[101]  C. Kaltschmidt,et al.  Glucocorticoid-mediated repression of cytokine gene transcription in human arteritis-SCID chimeras. , 1997, The Journal of clinical investigation.

[102]  J. Lie.  Aortic and extracranial large vessel giant cell arteritis: a review of 72 cases with histopathologic documentation. , 1995, Seminars in arthritis and rheumatism.

[103]  T Ido,et al.  Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[104]  R L Wahl,et al.  Serum glucose: effects on tumor and normal tissue accumulation of 2-[F-18]-fluoro-2-deoxy-D-glucose in rodents with mammary carcinoma. , 1992, Radiology.

[105]  D A Bloch,et al.  The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction. , 2010, Arthritis and rheumatism.

[106]  D A Bloch,et al.  The American College of Rheumatology 1990 criteria for the classification of vasculitis. Summary. , 2010, Arthritis and rheumatism.